Metaplanet
3350
Murata Manufacturing
6981
Mitsui O.S.K. Lines
9104
4
Alt
260A
5
Mitsubishi UFJ Financial Group
8306
JP Stock MarketDetailed Quotes
4888 Stella Pharma
- 327
- +8+2.51%
20min DelayMarket Closed May 1 15:30 JST
11.13BMarket Cap-13.26P/E (Static)
327High319Low105.40KVolume319Open319Pre Close34.08MTurnover60252wk High0.53%Turnover Ratio34.03MShares28152wk Low-22.92EPS TTM6.51BFloat Cap1070Historical HighLossP/E (Static)19.91MShs Float229Historical Low-24.66EPS LYR2.51%Amplitude--Dividend TTM3.61P/B100Lot Size--Div YieldTTM
About Stella Pharma Company
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
Company Profile
Symbol4888
Company NameStella Pharma
Founded2007-06-01
MarketTSE Growth
Fiscal Year Ends03-31
Address3-2-7 Korai-bashi Chuo-ku, Osaka Prefecture
Zip Code541-0043
Phone06-4707-1516
Websitewww.stella-pharma.co.jp
Company Executives
- Name
- Position
- Salary
- Koki Uehara
- Representative Director and President
- --
- Wako Yabu
- Director
- --
- Toshimitsu Hayashi
- Director
- --
- Takahiro Kido
- Director
- --
- Takashi Fukuchi
- Independent Director
- --
- Masaya Oonishi
- Independent Director
- --
- Kohei Tsujii
- Independent Director
- --